Disentangling treatment pathways for knee osteoarthritis: a study protocol for the TREATright study including a prospective cohort study, a qualitative study and a cost-effectiveness study

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

Disentangling treatment pathways for knee osteoarthritis : a study protocol for the TREATright study including a prospective cohort study, a qualitative study and a cost-effectiveness study. / Bruhn, Simon Majormoen; Ingelsrud, Lina Holm; Bandholm, Thomas; Skou, Soren Thorgaard; Schroder, Henrik M.; Reventlow, Susanne; Moller, Anne; Kjellberg, Jakob; Kallemose, Thomas; Troelsen, Anders.

I: BMJ Open, Bind 11, Nr. 7, 048411, 2021.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

Bruhn, SM, Ingelsrud, LH, Bandholm, T, Skou, ST, Schroder, HM, Reventlow, S, Moller, A, Kjellberg, J, Kallemose, T & Troelsen, A 2021, 'Disentangling treatment pathways for knee osteoarthritis: a study protocol for the TREATright study including a prospective cohort study, a qualitative study and a cost-effectiveness study', BMJ Open, bind 11, nr. 7, 048411. https://doi.org/10.1136/bmjopen-2020-048411

APA

Bruhn, S. M., Ingelsrud, L. H., Bandholm, T., Skou, S. T., Schroder, H. M., Reventlow, S., Moller, A., Kjellberg, J., Kallemose, T., & Troelsen, A. (2021). Disentangling treatment pathways for knee osteoarthritis: a study protocol for the TREATright study including a prospective cohort study, a qualitative study and a cost-effectiveness study. BMJ Open, 11(7), [048411]. https://doi.org/10.1136/bmjopen-2020-048411

Vancouver

Bruhn SM, Ingelsrud LH, Bandholm T, Skou ST, Schroder HM, Reventlow S o.a. Disentangling treatment pathways for knee osteoarthritis: a study protocol for the TREATright study including a prospective cohort study, a qualitative study and a cost-effectiveness study. BMJ Open. 2021;11(7). 048411. https://doi.org/10.1136/bmjopen-2020-048411

Author

Bruhn, Simon Majormoen ; Ingelsrud, Lina Holm ; Bandholm, Thomas ; Skou, Soren Thorgaard ; Schroder, Henrik M. ; Reventlow, Susanne ; Moller, Anne ; Kjellberg, Jakob ; Kallemose, Thomas ; Troelsen, Anders. / Disentangling treatment pathways for knee osteoarthritis : a study protocol for the TREATright study including a prospective cohort study, a qualitative study and a cost-effectiveness study. I: BMJ Open. 2021 ; Bind 11, Nr. 7.

Bibtex

@article{26337c9fc70745108f3db9c573ae805d,
title = "Disentangling treatment pathways for knee osteoarthritis: a study protocol for the TREATright study including a prospective cohort study, a qualitative study and a cost-effectiveness study",
abstract = "Introduction Knee osteoarthritis (OA) is associated with chronic knee pain and functional disability that negatively affect the ability to carry out normal daily activities. Patients are offered a large variety of nonsurgical treatments, often not in accordance with clinical guidelines. This observational study will provide a comprehensive overview of treatment pathways for knee OA during the first 2 years after consulting an orthopaedic surgeon, including timing and order of treatment modalities, predictors of treatment outcomes, cost-effectiveness of treatment pathways and patients' views on different treatment pathways.Methods and analysis Patients with primary referrals to an orthopaedic surgeon due to knee OA are consecutively invited to participate and fill out a questionnaire prior to their consultation with an orthopaedic surgeon. Follow-up questionnaires will be obtained at 6 and 24 months after inclusion. Based on a prospective cohort study design, including questionnaires and register data, we will (1) describe treatment pathways for knee OA during the first 2 years after consulting an orthopaedic surgeon; (2) describe the characteristics of patients choosing different treatment pathways; (3) develop predictive models for patient-self-determined classifications of good and poor treatment outcomes; (4) evaluate the cost-effectiveness of treatment pathways that live up to clinical guidelines versus pathways that do not; based on a qualitative study design using semistructured individual interviews, we will (5) describe the patients' perspectives on treatment pathways for knee OA.",
keywords = "MULTIVARIABLE PREDICTION MODEL, SAMPLE-SIZE, INDIVIDUAL PROGNOSIS, DIAGNOSIS TRIPOD, OUTCOME MEASURES, SELF-EFFICACY, VISUAL ANALOG, HIP, MANAGEMENT, EVENTS",
author = "Bruhn, {Simon Majormoen} and Ingelsrud, {Lina Holm} and Thomas Bandholm and Skou, {Soren Thorgaard} and Schroder, {Henrik M.} and Susanne Reventlow and Anne Moller and Jakob Kjellberg and Thomas Kallemose and Anders Troelsen",
year = "2021",
doi = "10.1136/bmjopen-2020-048411",
language = "English",
volume = "11",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "7",

}

RIS

TY - JOUR

T1 - Disentangling treatment pathways for knee osteoarthritis

T2 - a study protocol for the TREATright study including a prospective cohort study, a qualitative study and a cost-effectiveness study

AU - Bruhn, Simon Majormoen

AU - Ingelsrud, Lina Holm

AU - Bandholm, Thomas

AU - Skou, Soren Thorgaard

AU - Schroder, Henrik M.

AU - Reventlow, Susanne

AU - Moller, Anne

AU - Kjellberg, Jakob

AU - Kallemose, Thomas

AU - Troelsen, Anders

PY - 2021

Y1 - 2021

N2 - Introduction Knee osteoarthritis (OA) is associated with chronic knee pain and functional disability that negatively affect the ability to carry out normal daily activities. Patients are offered a large variety of nonsurgical treatments, often not in accordance with clinical guidelines. This observational study will provide a comprehensive overview of treatment pathways for knee OA during the first 2 years after consulting an orthopaedic surgeon, including timing and order of treatment modalities, predictors of treatment outcomes, cost-effectiveness of treatment pathways and patients' views on different treatment pathways.Methods and analysis Patients with primary referrals to an orthopaedic surgeon due to knee OA are consecutively invited to participate and fill out a questionnaire prior to their consultation with an orthopaedic surgeon. Follow-up questionnaires will be obtained at 6 and 24 months after inclusion. Based on a prospective cohort study design, including questionnaires and register data, we will (1) describe treatment pathways for knee OA during the first 2 years after consulting an orthopaedic surgeon; (2) describe the characteristics of patients choosing different treatment pathways; (3) develop predictive models for patient-self-determined classifications of good and poor treatment outcomes; (4) evaluate the cost-effectiveness of treatment pathways that live up to clinical guidelines versus pathways that do not; based on a qualitative study design using semistructured individual interviews, we will (5) describe the patients' perspectives on treatment pathways for knee OA.

AB - Introduction Knee osteoarthritis (OA) is associated with chronic knee pain and functional disability that negatively affect the ability to carry out normal daily activities. Patients are offered a large variety of nonsurgical treatments, often not in accordance with clinical guidelines. This observational study will provide a comprehensive overview of treatment pathways for knee OA during the first 2 years after consulting an orthopaedic surgeon, including timing and order of treatment modalities, predictors of treatment outcomes, cost-effectiveness of treatment pathways and patients' views on different treatment pathways.Methods and analysis Patients with primary referrals to an orthopaedic surgeon due to knee OA are consecutively invited to participate and fill out a questionnaire prior to their consultation with an orthopaedic surgeon. Follow-up questionnaires will be obtained at 6 and 24 months after inclusion. Based on a prospective cohort study design, including questionnaires and register data, we will (1) describe treatment pathways for knee OA during the first 2 years after consulting an orthopaedic surgeon; (2) describe the characteristics of patients choosing different treatment pathways; (3) develop predictive models for patient-self-determined classifications of good and poor treatment outcomes; (4) evaluate the cost-effectiveness of treatment pathways that live up to clinical guidelines versus pathways that do not; based on a qualitative study design using semistructured individual interviews, we will (5) describe the patients' perspectives on treatment pathways for knee OA.

KW - MULTIVARIABLE PREDICTION MODEL

KW - SAMPLE-SIZE

KW - INDIVIDUAL PROGNOSIS

KW - DIAGNOSIS TRIPOD

KW - OUTCOME MEASURES

KW - SELF-EFFICACY

KW - VISUAL ANALOG

KW - HIP

KW - MANAGEMENT

KW - EVENTS

U2 - 10.1136/bmjopen-2020-048411

DO - 10.1136/bmjopen-2020-048411

M3 - Journal article

C2 - 34233992

VL - 11

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 7

M1 - 048411

ER -

ID: 275057877